Successful Management of Hypertriglyceridemia‐Induced Acute Pancreatitis in Resource‐Limited Setting: A Case Report and Brief Review of the Literature Authors: Mukti Nath Sankhi, Sabin Rajbhandari, Ayush Rayamajhi, Pramila Dhakal, Nabin Adhikari, Santosh Kumar Singh Published: 2026 ABSTRACT ABSTRACTA 44‐year‐old man presented with acute abdominal pain and was diagnosed with hypertriglyceridemia‐induced acute pancreatitis. He was managed with fluid resuscitation, analgesia, and insulin infusion and had good recovery. Recognizing hypertriglyceridemia as an etiology of acute pancreatitis and insulin infusion as a treatment modality is important in a resource‐limited setting.Keywords: acute pancreatitis, diabetes mellitus, hypertriglyceridemia, insulin infusion, plasma exchange Introduction Acute pancreatitis is an acute inflammatory disorder of the pancreas with clinical manifestation ranging from mild, self‐limiting disease to severe necrotizing pancreatitis complicated by persistent organ failure. Gallstones and alcohol consumption remain the leading causes of acute pancreatitis worldwide, while hypertriglyceridemia is the third most common etiology, accounting for approximately 2%–10% of all cases [1, 2]. The incidence of hypertriglyceridemia‐induced acute pancreatitis (HTG‐AP) has increased over the past decade, paralleling the rising prevalence of type 2 diabetes mellitus and metabolic syndrome [3]. The risk of acute pancreatitis increases when serum triglyceride concentrations exceed 500 mg/dL and becomes particularly high at levels above 1000 mg/dL, with higher triglyceride levels associated with severe disease [4]. Poorly controlled diabetes mellitus is an important secondary cause of hypertriglyceridemia, as insulin deficiency or resistance reduces lipoprotein lipase activity and increases hepatic very‐low‐density lipoprotein (VLDL) synthesis. Consequently, severe hypertriglyceridemia may develop and precipitate acute pancreatitis, particularly in patients with poorly controlled diabetes [5, 6]. Management of HTG‐AP involves standard supportive care combined with rapid reduction of serum TG concentrations. Although therapeutic plasma exchange has been advocated in selected patients with severe disease, recent evidence increasingly supports intensive insulin therapy as an effective, less invasive, and widely available approach for reducing TG levels [7]. However, the optimal insulin regimen and the requirement of therapeutic plasma exchange remain subjects of ongoing debate. We report a case of acute pancreatitis secondary to severe hypertriglyceridemia in a patient with poorly controlled type 2 diabetes mellitus, successfully managed with intravenous insulin infusion in a low‐resource setting. This case highlights the importance of recognizing severe hypertriglyceridemia as an etiology of acute pancreatitis in patients with uncontrolled diabetes and demonstrates the practical use of intravenous insulin therapy for rapid triglyceride reduction. Case History A 42‐year‐old man presented to the emergency department with severe upper abdominal pain of 1‐day duration. The pain had a sudden onset, was predominantly epigastric, radiated to the back, and was associated with nausea and repeated vomiting. There was no history of alcohol consumption, gallstone disease, recent trauma, use of medications known to precipitate pancreatitis, or previous episodes of pancreatitis. He had been diagnosed with type 2 diabetes mellitus 8 years earlier and was receiving oral antidiabetic therapy; however, his glycemic control had been suboptimal. On examination, the patient appeared ill and dehydrated. He was afebrile, with a pulse rate of 112 beats/min, blood pressure of 96/60 mmHg, respiratory rate of 24 breaths/min, and oxygen saturation of 94% on room air. Abdominal examination revealed epigastric tenderness with normal bowel sounds. Differential Diagnosis, Investigations and Treatment Initial laboratory investigations revealed markedly elevated serum amylase and lipase levels, consistent with acute pancreatitis (Table 1). Random blood glucose was 260 mg/dL, and glycated hemoglobin (HbA1c) was 9.8%, indicating poor glycemic control. Liver function tests were within normal limits, with no biochemical evidence of biliary obstruction; serum calcium was also normal. Abdominal ultrasonography demonstrated features of acute pancreatitis without evidence of gallstones or biliary dilatation. A fasting serum lipid profile revealed severe hypertriglyceridemia, with a triglyceride concentration of 2846 mg/dL. The blood sample was grossly lipemic (Figure 1). In the absence of other identifiable etiologies and in the presence of severe hypertriglyceridemia, a diagnosis of HTG‐AP was established. Contrast‐enhanced computed tomography of the abdomen, performed 72 h after symptom onset, confirmed acute interstitial pancreatitis without pancreatic necrosis (Figure 2). During the first 24 h, the patient developed transient hypotension that responded to intravenous fluid resuscitation and an episode of desaturation; however, he did not develop persistent organ failure. Based on the Revised Atlanta Classification, the episode was classified as moderately severe acute pancreatitis. TABLE 1Relevant investigations of the patient.InvestigationOn admissionOn dischargeOn follow up (1 month)Reference valueHb (gm/dL)16.51413.612–15TLC (×103 μL)12.68.67.54–11Platelets (×103 μL)291260272150–400Urea (mg/dL)56343613–43Creatinine (mg/dL)1.51.11.00.6–1.1Sreum amylase (U/L)105813640< 80Serum lipase (U/L)8209236< 64Triglyceride (mg/dL)2846278226< 150RBS260178152< 140HbA1c9.8%Bilirubin total/direct (mg/dL)0.6/0.10.8/0.30.7/0.20.3–1.2ALT (U/L)25322813–40AST (U/L)22263413–40ALP54625842–128Serum calcium (mg/dL)9.2USG abdomenDiffusely enlarged, hypoechoic pancreas with heterogenous echotexture. Findings consistent with acute pancreatitisChest X‐ray PA viewBlunting of left costophrenic angle suggestive of minimal left pleural effusionCECT abdomenPeripancreatic fat stranding with bulky appearance of the pancreas suggestive of acute interstitial pancreatitisAbbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CECT, contrast enhanced computed tomography; Hb, hemoglobin; PA, posteroanterior view; RBS, random blood sugar; TLC, total leucocyte count; USG, ultrasonography. Relevant investigations of the patient. Abbreviations: ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CECT, contrast enhanced computed tomography; Hb, hemoglobin; PA, posteroanterior view; RBS, random blood sugar; TLC, total leucocyte count; USG, ultrasonography. Grossly lipemic blood sample from the patient. Contrast‐enhanced computed tomography showing peripancreatic fat stranding (blue arrow) and a bulky pancreas (orange arrow), consistent with acute pancreatitis. The patient was admitted to the high‐dependency unit (HDU) and managed with bowel rest, aggressive intravenous crystalloid fluid administration, opioid analgesia, electrolyte correction, and oxygen supplementation. A continuous intravenous infusion of regular insulin (0.1 U/kg/h) was initiated and titrated according to serial blood glucose measurements. Intravenous dextrose 5% in water (D5W) was administered as needed when blood glucose was below 250 mg/dL to maintain euglycemia while allowing uninterrupted insulin therapy until serum triglyceride levels declined below 500 mg/dL. Blood glucose levels were monitored hourly, the basic metabolic panel every 6 h, and serum triglycerides every 12 h. Serum triglyceride levels demonstrated a progressive decline, reaching < 500 mg/dL at 60 h, accompanied by clinical improvement (Figure 3). Serial serum triglyceride and blood glucose levels during treatment with intravenous insulin. The patient remained hemodynamically stable throughout the remainder of his hospitalization and did not require therapeutic plasma exchange or any other intervention. With gradual clinical improvement, oral feeding was resumed on the third day of admission. He was started on lipid‐lowering therapy (fenofibrate), counseled regarding adherence to a low‐fat diabetic diet, and educated about the importance of strict glycemic control. He was discharged in stable condition with advice for outpatient follow‐up. Follow Up and Outcome At the 1‐month follow‐up visit, glycemic control had improved, with fasting blood glucose level of 118 mg/dL and a 2‐h post prandial blood glucose level of 176 mg/dL. His serum triglyceride level had decreased to 226 mg/dL. Subcutaneous insulin along with his other oral antidiabetic medications and lipid‐lowering therapy was also continued. Discussion Hypertriglyceridemia is a well‐recognized cause of acute pancreatitis and should be considered in patients presenting with acute pancreatitis in the absence of gallstones or a history of alcohol use, particularly in those with diabetes mellitus or metabolic syndrome. A serum triglyceride concentration > 500 mg/dL is associated with an increased risk of acute pancreatitis. The risk increases substantially when TG levels exceed 1000 mg/dL and rises further at level > 2000 mg/dL [1]. Our patient had a TG level of 2846 mg/dL, well within the range associated with high risk of HTG‐AP. The exact pathogenesis of HTG‐AP induced acute pancreatitis remains incompletely understood. The most widely accepted mechanism involves the hydrolysis of excess triglycerides by pancreatic lipase, producing large quantities of free fatty acids. When the buffering capacity of albumin is exceeded, unbound free fatty acids aggregate into toxic micellar structures, causing acinar cell injury, endothelial dysfunction, pancreatic ischemia, and activation of inflammatory pathways. Hyperviscosity caused by chylomicrons further compromises pancreatic microcirculation, exacerbating ischemic injury [5]. Poor glycemic control likely contributed significantly to the development of severe hypertriglyceridemia in our patient. Insulin deficiency reduces lipoprotein lipase activity while increasing adipose tissue lipolysis and hepatic VLDL production, leading to profound hypertriglyceridemia [6]. The patient's HbA1c of 9.8% supports chronic inadequate glycemic control as an important risk factor. The management of HTP‐AP includes standard supportive care for acute pancreatitis, comprising aggressive intravenous crystalloid resuscitation, adequate analgesia, correction of electrolyte abnormalities, and early enteral nutrition as tolerated. In addition to these measures, rapid reduction of serum triglyceride concentration is a key therapeutic objective to limit ongoing pancreatic injury. Continuous intravenous insulin infusion is an effective first line treatment, particularly in patients with concomitant diabetes mellitus. Insulin enhances endothelial lipoprotein lipase activity, thereby accelerating the hydrolysis and clearance of triglyceride‐rich lipoproteins, while simultaneously suppressing hormone‐sensitive lipase, reducing the release of free fatty acids from adipose tissue. Published studies have consistently demonstrated a 50%–70% reduction in serum triglyceride concentration within the first 24 h of insulin therapy, with normalization usually achieved over the subsequent several days. In contrast, heparin is no longer recommended for routine triglycerides lowering because repeated administration depletes endothelial lipoprotein lipase stores and may increase the risk of bleeding without improving clinical outcomes [8, 9]. There is no universally standardized insulin regimen for the management of HTG‐AP. Yacine et al. compared a fixed‐dose intravenous insulin protocol against an institutional DKA protocol for the insulin therapy in HTG‐AP [10]. The fixed‐dose protocol used regular insulin at 0.1 units/kg/h with D10W, targeting blood glucose of 80–140 mg/dL; glucose was monitored every 30 min initially and hourly thereafter, while serum triglycerides and the basic metabolic panel were monitored every 12 and 6 h, respectively. Insulin therapy was continued until TG levels fell below 500 mg/dL. The institutional DKA protocol also used insulin at 0.1 units/kg/h, with a maximum of 12 units/h for patients > 115 kg, and initiated dextrose when glucose fell below 250 mg/dL. The insulin doses reported in other published evidence vary depending on whether the patient had pre‐existing diabetes (0.1 U/kg/h) or not (1–2 U/kg/day) and are typically adjusted by body weight and close clinical and biochemical monitoring [11]. In our patient, the institutional DKA protocol was used because of concomitant poorly controlled diabetes mellitus. Therapeutic plasma exchange (TPE) rapidly removes triglyceride‐rich lipoproteins from the circulation and can reduce serum triglyceride concentrations by 60%–80% after a single session. However, recent randomized controlled trials, systematic reviews, and meta‐analyses have not demonstrated consistent improvements in mortality, organ failure, intensive care unit length of stay, or other clinically meaningful outcomes compared with intensive medical management using insulin and supportive care. Current recommendations therefore reserve TPE for selected patients, such as those with persistent organ failure, refractory severe hypertriglyceridemia despite insulin therapy, pregnancy‐associated severe hypertriglyceridemia, or rapidly deteriorating clinical status [12, 13]. The AEG‐AESPANC‐OPGE‐SIED‐SPG Ibero‐Latin American Guidelines on Acute Pancreatitis states that blood purification methods may be considered on an individual basis in patients with very high TG levels (> 5000 mg/dL) who do not respond adequately to insulin therapy [8]. Our patient demonstrated rapid clinical and biochemical improvement with continuous insulin infusion alone, without requiring plasma exchange, reinforcing the growing body of evidence that intensive insulin therapy is an effective and practical first‐line treatment for hypertriglyceridemia‐induced acute pancreatitis, particularly in low‐resource setting. Long‐term management is essential to prevent recurrence of HTG‐AP. In patients with secondary risk factors like poorly controlled diabetes mellitus, glycemic optimization is a key component of management as uncontrolled hyperglycemia and insulin resistance can substantially increase triglyceride concentrations. Lifestyle modification should include dietary modification, regular physical activity, and weight reduction. Dietary recommendations should be individualized based on the magnitude of triglyceride elevation. In individuals with triglyceride levels ≥ 1000 mg/dL, added sugars should be eliminated, total fat intake should be restricted to approximately 10%–15% of total daily calorie intake, and alcohol should be completely avoided. In all patients with hypertriglyceridemia, regular physical activity should be encouraged, with a goal of at least 150 min per week of moderate‐intensity or 75 min per week of vigorous‐intensity aerobic exercise, or an equivalent combination of both. Resistance exercise should be performed at least twice weekly. For individuals who are overweight or obese, a weight reduction of approximately 5%–10% of body weight should be targeted. Fibrates are used as first‐line pharmacotherapy when triglyceride levels remain ≥ 500 mg/dL, while prescription omega‐3 fatty acids may be considered for persistent TG ≥ 500 mg/dL. Novel therapies targeting apolipoprotein C‐III (Olezarsen) may be used in cases of familial hypertriglyceridemia with fasting triglyceride more than 1000 mg/dL to prevent recurrent episodes in the future. Serum triglyceride should be monitored regularly, with a target of maintaining levels below 500 mg/dL. In patients with severe hypertriglyceridemia, genetic evaluation should be considered when marked triglyceride elevation persists or recurs despite correction of secondary causes, particularly in those with early‐onset disease, recurrent pancreatitis, suggestive family history, or a North American Familial Chylomicronemia Syndrome (NAFCS) Score ≥ 30. Genetic testing can help distinguish monogenic familial chylomicronemia syndrome from multifactorial chylomicronemia syndrome [14, 15, 16]. Our patient was prescribed oral fenofibrate 160 mg once daily in addition to lifestyle modification and antidiabetic therapy to optimize glycemic control, with sustained serum triglyceride levels below 500 mg/dL. Conclusion Hypertriglyceridemia should be considered as an etiology of acute pancreatitis, particularly in patients without gallstones or alcohol exposure and with poorly controlled diabetes. Early measurement of serum triglyceride levels is essential for establishing the diagnosis. Intravenous insulin infusion is a safe, effective, and readily available therapy that rapidly lowers triglyceride concentrations while simultaneously improving hyperglycemia. Current evidence does not support the routine use of therapeutic plasma exchange, which should be reserved for selected patients with severe or refractory disease. Long‐term prevention requires aggressive glycemic control, sustained triglyceride‐lowering therapy, dietary modification, and lifestyle intervention to reduce the risk of recurrence. Author Contributions Pramila Dhakal: conceptualization, writing – original draft, data curation, resources. Sabin Rajbhandari: conceptualization, writing – review and editing, supervision, visualization. Mukti Nath Sankhi: conceptualization, investigation, writing – original draft, resources, formal analysis, validation. Ayush Rayamajhi: writing – review and editing, resources, conceptualization. Nabin Adhikari: writing – review and editing, resources. Santosh Kumar Singh: supervision, conceptualization. Funding The authors have nothing to report. Ethics Statement All procedures performed in this study involving human participants were in accordance with the institutional review committee. Consent Written informed consent was obtained from the patient regarding publication of the data and images. Conflicts of Interest The authors declare no conflicts of interest. Acknowledgments The authors have nothing to report. Data Availability Statement The data used and/or analyzed during the current study are available from the corresponding author on reasonable request. References Associated Data Data Availability Statement The data used and/or analyzed during the current study are available from the corresponding author on reasonable request.